
Introduction: Lipid metabolism is closely linked to epithelial barrier integrity, but the causal effects of different lipid-lowering drug targets on mucosal barrier diseases across the digestive tract and ocular surface remain unclear. Methods: Using a drug-target Mendelian randomization approach with genome-wide association study and FinnGen data, we evaluated causal relationships between seven lipid-lowering drug targets— low-density lipoprotein receptor (LDLR), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), proprotein convertase subtilisin/kexin type 9 (PCSK9), Niemann-Pick C1-like 1 (NPC1L1), lipoprotein lipase (LPL), apolipoprotein C-III (APOC3), and angiopoietin-like 3 (ANGPTL3) and mucosal barrier diseases. Results: Genetically proxied triglyceride lowering mediated by both LPL activation and ANGPTL3 inhibition was significantly associated with reduced risk of gastroduodenal ulcer and gastric ulcer (ORLPL = 0.790 and 0.701; ORANGPTL3 = 0.660 and 0.523). Genetically proxied low-density lipoprotein cholesterol lowering mediated by LDLR activation was significantly associated with reduced risk of inflammatory bowel disease, ulcerative colitis, and Crohn's disease (OR = 0.732, 0.756, and 0.670), with the protective effect significant only in small-intestinal Crohn's disease (OR = 0.658). HMGCR inhibition reduced cholelithiasis risk (OR = 0.644), while PCSK9 inhibition increased it (OR = 1.248). Discussion: The restriction of the LDLR effect to small-intestinal Crohn's disease is consistent with a role for ileal bile acid reabsorption and cholesterol handling in mucosal immune regulation. The opposing biliary effects of HMGCR and PCSK9 suggest that targets that lower LDL-C may act through distinct mechanisms. Conclusion: Lipid-lowering drug targets show target- and organ-dependent differential effects on mucosal barrier diseases, supporting individualized drug selection and monitoring for mucosalrelated adverse effects during long-term lipid-lowering therapy.
Introduction: Rhizoma Coptidis, Radix Scutellariae, and Cortex Phellodendri are used to treat periodontitis. This study integrated network pharmacology and network toxicology to elucidate their principal active compounds, key targets, and potential toxicity. Methods: Using network pharmacology, differential expression analysis, and machine learning algorithms, key genes were identified from the intersection of genes associated with the active compounds of the three herbs and genes differentially expressed in periodontitis. Concurrently, single-cell analysis was performed to identify critical cell types, and key targets were identified by assessing their enrichment and expression patterns within these cell types. Molecular dynamics (MD) simulations were performed on complexes formed by the key targets and active compounds. Finally, the potential toxicity of the key active compounds and their corresponding targets was evaluated. Results: PLAT, SELE, IL1B, CXCL8, FOS, and MMP3 were identified as key genes associated with periodontitis and were significantly involved in inflammatory responses. CXCL8 emerged as a potential key target and was most highly expressed in macrophages, which were identified as a candidate cell type of interest. Integration of molecular docking and MD simulations showed that the CXCL8–quercetin complex underwent progressive structural stabilization and exhibited strong predicted binding affinity. Discussion: The three herbs may exert therapeutic effects against periodontitis through multicomponent, multi-target, and multi-pathway mechanisms. These computational predictions require further experimental validation of their efficacy and safety. Conclusion: The study identified macrophages as a candidate cell type of interest and CXCL8 as a potential target associated with herbal-component-mediated macrophage inflammation. Quercetin and wogonin were identified as core active compounds within Rhizoma Coptidis, Radix Scutellariae, and Cortex Phellodendri, with computationally predicted respiratory toxicity risks. These findings provide computational insights for further investigation of the potential mechanisms and safety of these herbal components in periodontitis.
Introduction: Although white blood cell count (WBC) is an accessible prognostic marker, the relationship between WBC-related genes and outcomes in acute myocardial infarction (AMI) remains unclear. Methods: A retrospective study of 1,917 patients with AMI was conducted to estimate prognostic indicators. Mendelian randomization (MR) analysis was used to identify potential genes associated with the prognostic indicators, and the resulting genes were intersected with differentially expressed genes from the key monocyte subset identified in single-cell RNA sequencing (scRNA-seq) analyses. Key genes were screened by integrating 52 machine learning algorithms. The expression of key genes was validated by RT-qPCR with clinical samples. In addition, an AMI mouse model was established, and the expression of related proteins was further validated by western blotting and immunohistochemistry. Results: Age, WBC, and serum potassium (K) level were identified as prognostic indicators for AMI. Eight key genes were identified. Gene set enrichment analysis (GSEA) showed that these genes were significantly enriched in immune- and inflammation-related pathways. RT-qPCR validation showed that the expression trends of five key genes (ITGA4, RASA3, ATG7, HSPA6, and ITGAM) were consistent with the bioinformatics results, whereas DSTN, FES, and MCL1 did not reach statistical significance. Additionally, WB and IHC further validated HSP70 family protein upregulation in the AMI mouse model. Discussion: Eight AMI-related genes were identified and might contribute to disease progression through inflammatory regulation. The integration of multi-omics analysis and experimental validation underscores the translational potential of these genes. Although further experimental validation is warranted, these findings may offer novel insights for the development of therapeutic strategies for AMI. Conclusion: This study identified eight key WBC-related genes that may serve as potential biomarkers for AMI.
Introduction: Acute respiratory distress syndrome (ARDS), frequently triggered by sepsis, is associated with high mortality and severe disruption of the alveolar-capillary barrier driven by immune dysregulation. This study aimed to characterize immune-stromal crosstalk in sepsis-induced ARDS and develop a predictive risk model. Methods: Bulk transcriptomic datasets were used for differential expression analysis, immune deconvolution, and development of a sepsis-to-ARDS risk model. eQTL-based Mendelian randomization evaluated associations between genetically predicted gene expression and sepsis susceptibility. Human and mouse single-cell datasets were used for pseudotime and inferred ligand-receptor communication analyses. Results: Ten core genes, including CD52 and MACF1, were prioritized by integrating ARDSassociated differential expression with genetic associations for sepsis susceptibility. CD52 showed dynamic expression changes in CD8+ T cells. CD52-low states were associated with stronger inferred MIF- and TGF-β-related communication and with transcriptional programs linked to immune recruitment and barrier dysfunction. The four-gene signature showed moderate discrimination in the external-validation cohort (AUC = 0.688). Discussion: These findings identify CD52 as a marker of a dynamic immunoregulatory state in sepsis- induced ARDS and associate CD52-low states with altered inferred T cell-stromal communication. The four-gene signature provides proof-of-concept support for transcriptomic risk stratification but requires further clinical validation. Conclusion: CD52 marks a time-dependent immune state associated with inferred T cell-stromal communication in sepsis-induced ARDS. The four-gene signature provides proof-of-concept support for risk stratification, while functional studies are required to determine whether CD52 directly modifies barrier-related signaling.
In the published version of this article [1], an error was identified by the author in the affiliations of Drs. Roopa Bhandary, Priya Alva, and Sukanya Shetty. The affiliations were incorrectly stated in the published article. This has now been corrected. This correction is limited to the authors’ affiliations and has no impact on the scientific content, results, discussion, or conclusions of the article. Details of the error and the correction are provided below. Original: Department of Biochemistry, K.S. Hegde Medical Academy, Mangalore, Karnataka, 575018, India Corrected: Department of Biochemistry, KS Hegde Medical Academy (KSHEMA), Nitte (Deemed to be University), Mangalore, 575018, India The corrected version of the article is available online at: https://www.benthamscience.com/article/145548 The authors regret the error and apologize for any inconvenience it may have caused.